To determine the effect of potassium supplementation on blood pressure in African Americans consuming a low-potassium diet.
Randomized, double-blind, placebocontrolled trial with two parallel arms.
Community-based research site.
Eighty-seven healthy African Americans aged 27 to 65 years with a systolic blood pressure between 100 and 159 mm Hg and a diastolic blood pressure between 70 and 94 mm Hg.
During the 21-day intervention period, all participants were provided with a low-potassium diet (32 to 35 mmol/d). In addition to this diet, they were randomly assigned to receive either potassium supplements (80 mmol/d) or placebo.
Main Outcome Measure:
Change in blood pressure in the potassium vs the placebo group, based on a total of nine blood pressure readings at three visits. Blood pressures were taken before and during the intervention by means of random-zero sphygmomanometry.
At baseline, the placebo and potassium groups were similar for mean blood pressure (127/78 vs 125/77 mm Hg), 24-hour urinary potassium excretion (50 vs 44 mmol), and all other variables measured (allP>.05). During the intervention, the net difference in 24-hour urinary potassium excretion between groups was 70 mmol. Compared with the placebo group, the potassium supplementation group experienced a net decline in systolic blood pressure of 6.9 mm Hg (95% confidence interval, —9.3 to —4.4 mm Hg; P<.001) and a decline in diastolic blood pressure of 2.5 mm Hg (95% confidence interval, —4.3 to —0.8 mm Hg; P=.004). Simultaneous adjustment for differences in baseline characteristics only strengthened these estimates.
Potassium supplementation reduces blood pressure substantially in African Americans consuming a diet low in potassium. Increased potassium intake may play an important role in reducing blood pressure in this population at high risk for hypertension.(Arch Intern Med. 1996;156:61-67)
Brancati FL, Appel LJ, Seidler AJ, Whelton PK. Effect of Potassium Supplementation on Blood Pressure in African Americans on a Low-Potassium DietA Randomized, Double-blind, Placebo-Controlled Trial. Arch Intern Med. 1996;156(1):61–67. doi:10.1001/archinte.1996.00440010079010
Customize your JAMA Network experience by selecting one or more topics from the list below.